Alnylam Pharmaceuticals, Inc.
$237.10
+0.54 (+0.23%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +15.4%
- 3 Months
- -21.5%
- YTD
- -40.4%
- 1 Year
- -47.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 46.1%
- Largest decline max drawdown, since Aug 2025
- -58.2%
- Risk-adjusted return Sharpe ratio, 1-year
- -1.16
Own ALNY?
See how ALNY contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.